Cell culture is one of the essential stages for producing the biosimilar antibodies. It helps in increasing the efficiency as well as productivity and thus, cuts the manufacturing cost. In the field of molecular biology, a cell culture is an important tool which offers the system for studying and analyzing normal physiology and biochemistry of cells. Cell culture is also used in drug screening and development and manufacturing of various biological compounds such as vaccines and therapeutic proteins. Moreover, increasing proteomic gene expression advancement and novel vaccine development along with biopharmaceuticals is projected to surge demand for advance 3D cell culturing methods. Furthermore, in recent years, cell culture market is having a huge demand owing to the rise of animal and human vaccines. It is also observed that the high-income of individuals in countries like the USA, UK are more looking forward to vaccines rather than low-income countries. Therefore, increasing rate of cancer study projects and growing application of gene therapies are the major drives responsible for the growth of the global cell culture market in the near future.
The global cell culture market is propelled by the increasing usage of single-use bioprocessing devices during the projection period. Moreover, it is noted that continuous development of healthcare sector along with a focus on research and development for improving the cell culture products which includes bioreactors, protein free, and sera are slaves some of the important factors which are anticipated to make the market demanding during the projection period. Another prime issue which is driving the market is growing production of biosimilar antibodies as this helps in increasing the efficiency along with productivity and thus reduces the cost of manufacturing. Growing demand for cell culture-based vaccines and stem cell research along with their huge application is also an essential factor fueling the growth of the global cell culture market.
The global cell culture market in the report is segmented by product type which includes equipment, and consumables. The equipment product type is further sub-segmented as incubators, roller bottle equipment, bioreactors, and others. Moreover, consumables type has been segmented into protein free, amino acids, fetal bovine sera, and others. Based on the application the market is analyzed as biopharmaceuticals, cancer research, tissue culture, gene therapy, and many more. Moreover, the global cell culture has been geographically segmented into North America, Europe, Asia-Pacific, Middle East and Africa and Latin America.
In addition to this, the presence of key players for expansion of this market in Asia-Pacific, makes the region hold the strongest growth for the cell culture market. Moreover, increasing research and development along with new drug supports by the key vendors in the United States and Canada is also making the market demanding in the North-America region. Rising prevalence of cancer and surging geriatric patient population in the U.S., Germany, Italy, and France, has also increased the demand for the cell culture in this region.
However, the high cost of cell biology research and development and lack of cell-based research in developing economies may impose a restriction on the growth of the global cell culture market.
Some of the major players in the global cell culture market include Becton, Dickinson and company, Biospherix Ltd., Cellgenix GmbH, Danaher Corporation, Ge Healthcare, Irvine Scientific, Lonze Group Limited, Merck Group, and VWR Internatinal LLC.
Global Cell Culture Market: By Product Type
Global Cell Culture Market: By Application
Global Cell Culture Market: By Geography